Dolo-650 makers spent Rs 1,000 cr on freebies to doctors to prescribe drug - BusinessToday
Udruženje doktora poridične medicine RS - SEMINAR DIJABETES I KOMPLIKACIJE
NPPA fixes retail prices of 23 drug formulations - The Economic Times
 "FabiFlu: India's first COVID-19 drug launched, priced at Rs 103 per tablet")
FabiFlu: India's first COVID-19 drug launched, priced at Rs 103 per tablet
Ayurvedic medicine scam: Accused sold medicines worth Rs 1 crore, bought SUV and properties in Delhi and Lucknow | Delhi News, The Indian Express
Predace 8mg Tablet 10'S - Buy Medicines online at Best Price from Netmeds.com
Udruženje doktora poridične medicine RS - Ibandronska kiselina standard u liječenju osteoporoze
A Rs-100 Med Tablet Gives Traders Profit Margin of Over 1000%, Shows Drug Price Watchdog's Analysis - News18
Dolo 650 Maker Micro Labs Rejects Allegations Of Rs 1,000 Crore Worth Freebies To Doctors
Dolo breaks sales record; sells over 350 crore pills during COVID-19 pandemic - BusinessToday
India Covid pill: India's first Covid antiviral pill costs Rs 35; set to hit market soon - The Economic Times Video | ET Now
A serious issue, will look into it': Supreme Court on claim that Dolo firm gave freebies to docs | India News,The Indian Express
Micro Labs gets clean chit from pharma body on allegations of spending Rs 1,000 crore on Dolo 650
Why Companies are Selling Same Drug in Different Prices? : Pharmaguideline
Methamphetamine tablets worth Rs 15 crore seized in Mizoram | North East India News,The Indian Express
Female Pelvic Medicine and Reconstructive Surgery Subspecialty | ABU
US Pharmacopeia (USP)
Dolo-650 Tablet Makers Bribed Doctors With Freebies Worth Rs 1,000 Crore To Prescribe Drug
Dolo pill breaks sales record in pandemic as manufacturer makes a fortune | Deccan Herald
RS Medical
Coronavirus India | Cipla to soon launch COVID-19 drug Ciplenza at Rs 68 per tablet
 "Lupin eyes Rs 2,500-crore market with its latest launch in US; what Anil Singhvi recommends | Zee Business")
Lupin eyes Rs 2,500-crore market with its latest launch in US; what Anil Singhvi recommends | Zee Business
